Introduction of adjuvant immunotherapy into the renal surgery pathway: Are eligible patients receiving treatment in time in the UK NHS setting?
Published online on January 19, 2026
Abstract
Journal of Clinical Urology, Volume 19, Issue 2, Page 211-218, March 2026.
Objective:The objective of the study is to identify uptake of adjuvant immunotherapy (AIO) and assess patient outcomes following partial or total nephrectomy for renal cell carcinoma (RCC).Patient and methods:Electronic health records of all patients who ...
Objective:The objective of the study is to identify uptake of adjuvant immunotherapy (AIO) and assess patient outcomes following partial or total nephrectomy for renal cell carcinoma (RCC).Patient and methods:Electronic health records of all patients who ...